Dexamethasone effects in the Strongyloides venezuelensis infection in A murine model

American Journal of Tropical Medicine and Hygiene

Volumn 84, Issue 6, 2011, Pages 957-966

  Machado, Eleuza R ^a,b   Carlos, Daniela ^a   Sorgi, Carlos A ^a   Ramos, Simone G ^a   Souza, Daniela I ^a   Soares, Edson G ^a   Costa Cruz, Julia M ^c   Ueta, Marlene T ^d   Aronoff, David M ^e   Faccioli, Lúcia H ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b Faculdade Anhanguera de Brasília   (Brazil)

^c FEDERAL UNIVERSITY OF UBERLÂNDIA   (Brazil)

^d UNIVERSITY OF CAMPINAS   (Brazil)

^e UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; GAMMA INTERFERON; IMMUNOGLOBULIN E ANTIBODY; IMMUNOGLOBULIN G1 ANTIBODY; IMMUNOGLOBULIN G2A ANTIBODY; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 3; INTERLEUKIN 4; INTERLEUKIN 5; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY BLOOD LEVEL; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; EOSINOPHIL; FERTILITY; IMMUNE RESPONSE; IMMUNOMODULATION; LUNG; LUNG LAVAGE; MALE; MONONUCLEAR CELL; MOUSE; NONHUMAN; PERITONEAL FLUID; PROTEIN BLOOD LEVEL; RAT; STRONGYLOIDIASIS;

ANIMALS; BRONCHOALVEOLAR LAVAGE FLUID; CYTOKINES; DEXAMETHASONE; DISEASE MODELS, ANIMAL; EOSINOPHILS; FECES; FEMALE; FERTILITY; HOST-PARASITE INTERACTIONS; IMMUNOGLOBULIN G; INTESTINES; LEUKOCYTES, MONONUCLEAR; LUNG; MALE; MICE; MICE, INBRED BALB C; PARASITE EGG COUNT; RATS; RATS, WISTAR; STRONGYLOIDES; STRONGYLOIDIASIS;

ANIMALIA; MURINAE; MUS; NEMATODA; STRONGYLOIDES VENEZUELENSIS;

EID: 79958762042     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.2011.10-0490     Document Type: Article

References (50)

1. Grove DI, 1996. Human strongyloidiasis. Adv Parasitol 38: 251-309. (Pubitemid 26289928)
2. Ramanathan R, Nutman T, 2008. Strongyloides stercoralis infection in the immunocompromised host. Curr Infect Dis Rep 10: 105-110.
3. Montes M, Sanchez C, Verdonck K, Lake JE, Gonzalez E, Lopez G, Terashima A, Nolan T, Lewis DE, Gotuzzo E, White AC Jr, 2009. Regulatory T cell expansion in HTLV-1 and strongyloidiasis co-infection is associated with reduced IL-5 responses to Strongyloides stercoralis antigen. PLoS Negl Trop Dis 3: e456.
4. El Masry HZ, O'Donnell J, 2005. Fatal stongyloides hyperinfection in heart transplantation. J Heart Lung Transplant 11: 1980-1983. (Pubitemid 41641879)
5. Keiser PB, Nutman TB, 2004. Strongyloides stercoralis in the immunocompromised population. Clin Microbiol Rev 1: 208-217. (Pubitemid 38120934)
6. Guyomard JL, Chevrier S, Bertholom JL, Guigen C, Charlin JF, 2007. Finding of Strongyloides stercoralis infection, 25 years after leaving the endemic area, upon corticotherapy for ocular trauma. J Fr Ophtalmol 30: e4.
7. Ghosh K, Ghosh K, 2007. Strongyloides stercoralis septicaemia following steroid therapy for eosinophilia: report of three cases. Trans R Soc Trop Med Hyg 101: 1163-1165. (Pubitemid 47440536)
8. Marathe A, Date V, 2008. Strongyloides stercoralis hyperinfection in an immunocompetent patient with extreme eosinophilia. J Parasitol 94: 759-760. (Pubitemid 351999788)
9. Barnes PJ, 1998. Anti-inflammatory actions of glucocorticoids: molecular mechanisms. Clin Sci (Lond) 94: 557-572. (Pubitemid 28269054)
10. King EM, Holden NS, Gong W, Rider CF, Newton R, 2009. Inhibition of NF-kappaB-dependent transcription by MKP-1: transcriptional repression by glucocorticoids occurring via p38 MAPK. J Biol Chem 284: 26803-26815.
11. Kita H, Jorgensen RK, Reed CE, Dunnette SL, Swanson MC, Bartemes KR, Squillace D, Blomgren J, Bachman K, Gleich GJ, 2000. Mechanism of topical glucocorticoid treatment of hay fever: IL-5 and eosinophil activation during natural allergen exposure are suppressed, but IL-4, IL-6, and IgE antibody production are unaffected. J Allergy Clin Immunol 106: 521-529. (Pubitemid 32037705)
12. Jabara HH, Brodeur SR, Geha RS, 2001. Glucocorticoids upregulate CD40 ligand expression and induce CD40L-dependent immunoglobulin isotype switching. J Clin Invest 107: 371-378. (Pubitemid 32157969)
13. Nagase H, Miyamasu M, Yamaguchi M, Fujisawa T, Kawasaki H, Ohta K, Yamamoto K, Morita Y, Hirai K, 2001. Regulation of chemokine receptor expression in eosinophils. Int Arch Allergy Immunol 125 (Suppl 1): 29-32. (Pubitemid 32620157)
14. Oehling AG, Akdis CA, Schapowal A, Blaser K, Schmitz M, Simon HU, 1997. Suppression of the immune system by oral glucocorticoid therapy in bronchial asthma. Allergy 52: 144-154. (Pubitemid 27138427)
15. Lee E, Lindo T, Jackson N, Meng-Choong L, Reynolds P, Hill A, Haswell M, Jackson S, Kilfeather S, 1999. Reversal of human neutrophil survival by leukotriene B(4) receptor blockade and 5-lipoxygenase and 5-lipoxygenase activating protein inhibitors. Am J Respir Crit Care Med 160: 2079-2085. (Pubitemid 30004722)
16. Luo JC, Lin HY, Lu CL, Wang LY, Chang FY, Lin HC, Huang YC, Ng KM, Chi CW, Lee SD, 2008. Dexamethasone inhibits basic fibroblast growth factor-stimulated gastric epithelial cell proliferation. Biochem Pharmacol 76: 841-849.
17. Machado ER, Ueta MT, Lourenco EV, Anibal FF, Sorgi CA, Soares EG, Roque-Barreira MC, Medeiros AI, Faccioli LH, 2005. Leukotrienes play a role in the control of parasite burden in murine strongyloidiasis. J Immunol 175: 3892-3899. (Pubitemid 41292049)
18. Pan J, Ju D, Wang Q, Zhang M, Xia D, Zhang L, Yu H, Cao X, 2001. Dexamethasone inhibits the antigen presentation of dendritic cells in MHC class II pathway. Immunol Lett 76: 153-161. (Pubitemid 32295935)
19. Singer M, Lefort J, Vargaftig BB, 2002. Granulocyte depletion and dexamethasone differentially modulate airways hyperreactivity, inflammation, mucus accumulation, and secretion induced by rmIL-13 or antigen. Am J Respir Cell Mol Biol 26: 74-84. (Pubitemid 34029823)
20. Stankova J, Turcotte S, Harris J, Rola-Pleszczynski M, 2002. Modulation of leukotriene B4 receptor-1 expression by dexamethasone: potential mechanism for enhanced neutrophil survival. J Immunol 168: 3570-3576. (Pubitemid 34250427)
21. Michlewska S, Dransfield I, Megson IL, Rossi AG, 2009. Macrophage phagocytosis of apoptotic neutrophils is critically regulated by the opposing actions of pro-inflammatory and anti-inflammatory agents: key role for TNF-alpha. FASEB J 23: 844-854.
22. Genta RM, 1992. Dysregulation of strongyloidiasis: a new hypothesis. Clin Microbiol Rev 5: 345-355.
23. Brumpt E, 1934. Précis de Parasitologie, 6th ed. Paris, France: Masson et Cie, 1042-1047.
24. Gordon HM, Whitlock HVA, 1939. New technique for counting nematode eggs in sheep feces. J Comm Sci Ind Organiz 12: 17-18.
25. Rey, L. 2008. Parasitologia. 4a ed., Ed. Guanabara Koogan, Rio de Janeiro, Brasil.
26. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ, 1951. Protein measurement with the Folin phenol reagent. J Biol Chem 193: 265-275.
27. Berk SL, Verghese A, 1988. Parasitic pneumonia. Semin Respir Infect 3: 172-178.
28. McGowan JE Jr, Chesney PJ, Crossley KB, LaForce FM, 1992. Guidelines for the use of systemic glucocorticosteroids in the management of selected infections. Working Group on Steroid Use, Antimicrobial Agents Committee, Infectious Diseases Society of America. J Infect Dis 165: 1-13.
29. Luzi G, Lagana B, Salemi S, Di Rosa R, 2009. Are glucocorticoids a consistent risk factor for infections in rheumatoid arthritis patients under treatment with methotrexate and etanercept? Clin Ter 160: 121-123.
30. Rassi A, Amato Neto V, de Siqueira AF, Ferriolli Filho F, Amato VS, Rassi Junior A, 1999. Protective effect of benznidazole against parasite reactivation in patients chronically infected with Trypanosoma cruzi and treated with corticoids for associated diseases. Rev Soc Bras Med Trop 32: 475-482. (Pubitemid 29526792)
31. Maio P, Leone S, Volpe S, dell'Aquila G, Giglio S, Magliocca M, Nigro FS, Pacifico P, Acone N, 2009. Visceral leishmaniasis in a patient with common variable immunodeficiency and evans syndrome: clinical remarks. New Microbiol 32: 223-227.
32. Kim SK, Karasov A, Boothroyd JC, 2007. Bradyzoite-specific surface antigen SRS9 plays a role in maintaining Toxoplasma gondii persistence in the brain and in host control of parasite replication in the intestine. Infect Immun 75: 1626-1634. (Pubitemid 46559426)
33. Adjei AA, Jones JT, Enriquez FJ, Yamamoto S, 1999. Dietary nucleosides and nucleotides reduce Cryptosporidium parvum infection in dexamethasone immunosuppressed adult mice. Exp Parasitol 92: 199-208. (Pubitemid 29370063)
34. Abaza SM, Makhlouf LM, el-Shewy KA, el-Moamly AA, 1995. Intestinal opportunistic parasites among different groups of immunocompromised hosts. J Egypt Soc Parasitol 25: 713-727.
35. Rodrigues MA, Froes RC, Anefalos A, Kobayasi S, 2001. Invasive enteritis by Strongyloides stercoralis presenting as acute abdominal distress under corticosteroid therapy. Rev Hosp Clin Fac Med Sao Paulo 56: 103-106.
36. Pinatelle P, De Monbrison F, Bedock B, 2009. Disseminated strongyloidiasis with parasitemia in a patient under corticosteroid-treatment. Med Mal Infect 39: 267-269.
37. Pyrrho Ados S, Ramos JA, Neto RM, Silva CS, Lenzi HL, Takiya CM, Gattass CR, 2002. Dexamethasone, a drug for attenuation of Schistosoma mansoni infection morbidity. Antimicrob Agents Chemother 46: 3490-3498. (Pubitemid 35192916)
38. Yoshikawa H, Nakajima Y, Tasaka K, 1999. Glucocorticoid suppresses autocrine survival of mast cells by inhibiting IL-4 production and ICAM-1 expression. J Immunol 162: 6162-6170. (Pubitemid 29314978)
39. Lambroza A, Dannenberg AJ, 1991. Eosinophilic ascites due to hyperinfection with Strongyloides stercoralis. Am J Gastroenterol 86: 89-91.
40. Korenaga M, Hitoshi Y, Yamaguchi N, Sato Y, Takatsu K, Tada I, 1991. The role of interleukin-5 in protective immunity to Strongyloides venezuelensis infection in mice. Immunology 72: 502-507.
41. Watanabe K, Sasaki O, Hamano S, Kishihara K, Nomoto K, Tada I, Aoki Y, 2003. Strongyloides ratti: the role of interleukin-5 in protection against tissue migrating larvae and intestinal adult worms. J Helminthol 77: 355-361. (Pubitemid 37463214)
42. Tegoshi T, Okada M, Nishida M, Arizono N, 1997. Early increase of gut intraepithelial mast cell precursors following Strongyloides venezuelensis infection in mice. Parasitology 114: 181-187. (Pubitemid 27095223)
43. Tefé-Silva C, Souza DI, Ueta MT, Floriano EM, Faccioli LH, Ramos SG, 2008. Interference of dexamethasone in the pulmonary cycle of Strongyloides venezuelensis in rats. Am J Trop Med Hyg 79: 571-578.
44. Obinata H, Yokomizo T, Shimizu T, Izumi T, 2003. Glucocorticoids up-regulate leukotriene B4 receptor-1 expression during neutrophilic differentiation of HL-60 cells. Biochem Biophys Res Commun 309: 114-119. (Pubitemid 36999766)
45. Heuft HG, Goudeva L, Schwella N, Blasczyk R, 2004. Collection of two consecutive neutrophil concentrates for transfusion from donors mobilized with glycosylated granulocyte-CSF plus dexamethasone. Transfusion 44: 750-757. (Pubitemid 38608254)
46. Soda K, Kawabori S, Perdue MH, Bienenstock J, 1991. Macrophage engulfment of mucosal mast cells in rats treated with dexamethasone. Gastroenterology 100: 929-937.
47. Hermeto MV, Bicalho RS, da Silva RE, de Melo AL, Pereira LH, 1994. Oogram studies in mice infected with Schistosoma mansoni and treated with dexamethasone. Rev Inst Med Trop Sao Paulo 36: 99-104.
48. Ishikawa N, 1994. Histochemical characteristics of the goblet cell mucins and their role in defence mechanisms against Nippostrongylus brasiliensis infection in the small intestine of mice. Parasite Immunol 16: 649-654.
49. McMaster RP, Huffman JE, Fried B, 1995. The effect of dexamethasone on the course of Echinostoma caproni and E. trivolvis infections in the golden hamster (Mesocricetus auratus). Parasitol Res 81: 518-521.
50. Lim S, Katz K, Krajden S, Fuksa M, Keystone JS, Kain KC, 2004. Complicated and fatal Strongyloides infection in Canadians: risk factors, diagnosis and management. CMAJ 171: 479-484. (Pubitemid 39179611)